Skip to content

Toggle menu

Home
Management
Product Pipeline
Contact
News

Product Pipeline Graph

Recent News: 2018 Asco Annual Meeting

Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux –M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406).

About ABT-414/806

Please Click Here

© 2025 . Proudly powered by Sydney